207 related articles for article (PubMed ID: 31500407)
1. Sequence-Specific Mucins for Glycocalyx Engineering.
Pan H; Colville MJ; Supekar NT; Azadi P; Paszek MJ
ACS Synth Biol; 2019 Oct; 8(10):2315-2326. PubMed ID: 31500407
[TBL] [Abstract][Full Text] [Related]
2. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of incomplete O-glycan synthesis in MCF-7 breast cancer cells: putative role of MUC6 in Tn antigen expression.
Freire T; Bay S; von Mensdorff-Pouilly S; Osinaga E
Cancer Res; 2005 Sep; 65(17):7880-7. PubMed ID: 16140958
[TBL] [Abstract][Full Text] [Related]
4. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells.
Huang J; Byrd JC; Yoon WH; Kim YS
Oncol Res; 1992; 4(11-12):507-15. PubMed ID: 1284381
[TBL] [Abstract][Full Text] [Related]
5. Exploring the glycosylation of mucins by use of O-glycodomain reporters recombinantly expressed in glycoengineered HEK293 cells.
Konstantinidi A; Nason R; Čaval T; Sun L; Sørensen DM; Furukawa S; Ye Z; Vincentelli R; Narimatsu Y; Vakhrushev SY; Clausen H
J Biol Chem; 2022 Apr; 298(4):101784. PubMed ID: 35247390
[TBL] [Abstract][Full Text] [Related]
6. Chemically tunable mucin chimeras assembled on living cells.
Kramer JR; Onoa B; Bustamante C; Bertozzi CR
Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12574-9. PubMed ID: 26420872
[TBL] [Abstract][Full Text] [Related]
7. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression.
Brockhausen I; Yang J; Lehotay M; Ogata S; Itzkowitz S
Biol Chem; 2001 Feb; 382(2):219-32. PubMed ID: 11308020
[TBL] [Abstract][Full Text] [Related]
8. Kinetic modeling confirms the biosynthesis of mucin core 1 (beta-Gal(1-3) alpha-GalNAc-O-Ser/Thr) O-glycan structures are modulated by neighboring glycosylation effects.
Gerken TA
Biochemistry; 2004 Apr; 43(14):4137-42. PubMed ID: 15065856
[TBL] [Abstract][Full Text] [Related]
9. Mammalian reproductive tract mucins.
Lagow E; DeSouza MM; Carson DD
Hum Reprod Update; 1999; 5(4):280-92. PubMed ID: 10465520
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mucin synthesis by benzyl-alpha-GalNAc in KATO III gastric cancer and Caco-2 colon cancer cells.
Byrd JC; Dahiya R; Huang J; Kim YS
Eur J Cancer; 1995; 31A(9):1498-505. PubMed ID: 7577079
[TBL] [Abstract][Full Text] [Related]
11. Mucins and the Microbiome.
Hansson GC
Annu Rev Biochem; 2020 Jun; 89():769-793. PubMed ID: 32243763
[TBL] [Abstract][Full Text] [Related]
12. Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination.
Freire T; Lo-Man R; Piller F; Piller V; Leclerc C; Bay S
Glycobiology; 2006 May; 16(5):390-401. PubMed ID: 16449349
[TBL] [Abstract][Full Text] [Related]
13. In vivo glycosylation of mucin tandem repeats.
Silverman HS; Parry S; Sutton-Smith M; Burdick MD; McDermott K; Reid CJ; Batra SK; Morris HR; Hollingsworth MA; Dell A; Harris A
Glycobiology; 2001 Jun; 11(6):459-71. PubMed ID: 11445551
[TBL] [Abstract][Full Text] [Related]
14.
Taniguchi T; Woodward AM; Magnelli P; McColgan NM; Lehoux S; Jacobo SMP; Mauris J; Argüeso P
J Biol Chem; 2017 Jun; 292(26):11079-11090. PubMed ID: 28487369
[TBL] [Abstract][Full Text] [Related]
15. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
[TBL] [Abstract][Full Text] [Related]
16. Mucin-type O-glycosylation in Fasciola hepatica: characterisation of carcinoma-associated Tn and sialyl-Tn antigens and evaluation of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
Freire T; Casaravilla C; Carmona C; Osinaga E
Int J Parasitol; 2003 Jan; 33(1):47-56. PubMed ID: 12547345
[TBL] [Abstract][Full Text] [Related]
17. Mucin-type O-glycosylation in helminth parasites from major taxonomic groups: evidence for widespread distribution of the Tn antigen (GalNAc-Ser/Thr) and identification of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
Casaravilla C; Freire T; Malgor R; Medeiros A; Osinaga E; Carmona C
J Parasitol; 2003 Aug; 89(4):709-14. PubMed ID: 14533679
[TBL] [Abstract][Full Text] [Related]
18. Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.
Madsen CB; Lavrsen K; Steentoft C; Vester-Christensen MB; Clausen H; Wandall HH; Pedersen AE
PLoS One; 2013; 8(9):e72413. PubMed ID: 24039759
[TBL] [Abstract][Full Text] [Related]
19. Mucins in the gastrointestinal tract in health and disease.
Corfield AP; Carroll D; Myerscough N; Probert CS
Front Biosci; 2001 Oct; 6():D1321-57. PubMed ID: 11578958
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and analysis of the mouse homologue of the tumor-associated mucin, MUC1, reveals conservation of potential O-glycosylation sites, transmembrane, and cytoplasmic domains and a loss of minisatellite-like polymorphism.
Spicer AP; Parry G; Patton S; Gendler SJ
J Biol Chem; 1991 Aug; 266(23):15099-109. PubMed ID: 1714452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
